Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 36 (7) , 832-840
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Diagnostic Yield of Bone Marrow and Peripheral Blood FISH Panel Testing in Clinically Suspected Myelodysplastic Syndromes and/or Acute Myeloid LeukemiaAmerican Journal of Clinical Pathology, 2011
- Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesMolecular Cytogenetics, 2010
- Fluorescence In Situ Hybridization Testing for −5/5q, −7/7q, +8, and del(20q) in Primary Myelodysplastic Syndrome Correlates With Conventional Cytogenetics in the Setting of an Adequate StudyAmerican Journal of Clinical Pathology, 2010
- High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survivalBlood, 2008
- DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromesCytogenetic and Genome Research, 2007
- Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromesLeukemia & Lymphoma, 2007
- Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q DeletionNew England Journal of Medicine, 2006
- High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberrationLeukemia, 2006
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Primary myelodysplastic syndrome with normal cytogenetics: utility of ‘FISH panel testing’ and M-FISHLeukemia Research, 2002